EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy

Mehmet Orkun Sevik iD, Aslan Aykut iD, Furkan Çam iD, Volkan Dericioğlu iD, Özlem Şahin iD

Ophthalmic and Physiological Optics · 2023-09 · 43 (5) · 1203-1210

DOI: 10.1111/opo.13187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 15.06.2023. Verfasst von Mehmet Orkun Sevik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Phototherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the choroidal vascularity index (CVI) as an activity criterion in chronic central serous chorioretinopathy (CSC) and as a measure of treatment response after full‐dose‐full‐fluence photodynamic therapy (fd‐ff‐PDT).

Methods

This fellow‐eye‐controlled, retrospective cohort study included 23 patients with unilateral chronic CSC treated with fd‐ff‐PDT (6 mg/m 2 ; 50 μcm 2 ; 83 s). Subfoveal choroidal thickness (SFCT, μm) and CVI (%) of the affected and fellow eyes at baseline as well as at 1, 3 and 6 months after fd‐ff‐PDT were compared.

Results

The patients' mean age was 43.4 ± 7.3 years, and 18 (78.3%) were male. CVI was comparable between the affected and fellow eyes at baseline (66.09 ± 1.56 vs. 65.84 ± 1.57, p = 0.59). However, it became significantly lower in the affected eyes 1 (64.45 ± 1.68 vs. 65.87 ± 1.19, p = 0.002), 3 (64.21 ± 2.08 vs. 65.71 ± 1.59, p = 0.009) and 6 (64.47 ± 2.19 vs. 65.62 ± 1.52, p = 0.045) months after fd‐ff‐PDT. The mean SFCT and the mean CVI were significantly decreased in the affected eyes at all follow‐up visits compared with baseline after fd‐ff‐PDT ( p < 0.001).

Conclusion

At baseline, CVI was comparable between affected and fellow eyes. Therefore, its use as an activity criterion in chronic CSC patients is questionable. However, it was significantly decreased in fd‐ff‐PDT‐treated eyes, supporting its role as a measure of treatment response in chronic CSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyPhototherapyHumansMaleFemaleAdultMiddle AgedAgedVisual AcuityTomography, Optical CoherenceRetrospective StudiesChoroidChronic DiseaseTreatment Outcome

Stichwörter der Autor:innen

central serous chorioretinopathychoroidal vascularity indexsubfoveal choroidal thickness

Autor:innen und Institutionen

  • Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey.

ORCID-Profile: Mehmet Orkun Sevik, Aslan Aykut, Furkan Çam, Volkan Dericioğlu, Özlem Şahin

Zitieren

APA

Sevik, M. O., Aykut, A., Çam, F., Dericioğlu, V., & Şahin, Ö. (2023). Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy. Ophthalmic and Physiological Optics, 43(5), 1203-1210. https://doi.org/10.1111/opo.13187

Vancouver

Sevik MO, Aykut A, Çam F, Dericioğlu V, Şahin Ö. Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy. Ophthalmic and Physiological Optics. 2023;43(5):1203-1210. doi:10.1111/opo.13187

BibTeX
@article{Sevik2023,
  author = {Sevik, Mehmet Orkun and Aykut, Aslan and Çam, Furkan and Dericioğlu, Volkan and Şahin, Özlem},
  title = {Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy},
  journal = {Ophthalmic and Physiological Optics},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {1203--1210},
  doi = {10.1111/opo.13187}
}
Kostenlos starten →